31.63MMarket Cap-486P/E (TTM)
1.080High1.040Low248.49KVolume1.050Open1.050Pre Close264.51KTurnover2.18%Turnover RatioLossP/E (Static)29.84MShares22.22052wk High0.32P/B12.07MFloat Cap0.87052wk Low--Dividend TTM11.39MShs Float23.580Historical High--Div YieldTTM3.81%Amplitude0.870Historical Low1.064Avg Price1Lot Size
AN2 Therapeutics Stock Forum
Phase 3 continues for 97 patients enrolled before the voluntary enrollment pause; lifting of the Phase 3 enrollment pause to be determined after review of unblinded Phase 2 data and discussions with the FDA
4 dollar is their initial price
so hopeless at this price now
No comment yet